Participant evaluation Conference Highlights & Feedback What was the most valuable or enjoyable aspect of the conference for you? (e.g., Specific session, speaker, networking opportunity, location, ...) Do you have any suggestions for improvement for the next conference? Thank you for the Quick feedback above. This is very usefull to the Conference Programming Working Group.If you want to help us even more we would be grateful if you filled out the full evaluation on content and speakers programmed in Antwerp last week.Just click the "Yes, I am up for it" option below. You want to fill out the full evaluation form? Yes, I am up for it No, thanks General organisation, location, conference office General evaluation (Poor 1 - 2 - 3 - 4 - 5 Excellent) 12345 Comments, remarks, questions, complaints, ... ? All feedback is welcome Session 1 - (Novel) Approaches in BioRisk AssessmentsEnhancing Biosafety Risk Assessments through technology and interactive tools: the role of WHO RAST in laboratory settingsBy Sandhya Dhawan Content (Poor 1 - 2 - 3 - 4 - 5 Excellent) 12345 Speaker (knowlegde, language, QA, ...) (Poor 1 - 2 - 3 - 4 - 5 Excellent) 12345Generic downscaling of containment requirements for work with viral replicons derived from alphaviruses and flavivirusesBy Clara Posthuma Content (Poor 1 - 2 - 3 - 4 - 5 Excellent) 12345 Speaker (knowledge, language, QA, ...) (Poor 1 - 2 - 3 - 4 - 5 Excellent) 12345Sleeper Agents in vertebrate DNA: Do Endogenous Retroviruses Pose Hidden Risks?By Yaël Vanden Abeele Content (Poor 1 - 2 - 3 - 4 - 5 Excellent) 12345 Speaker (knowledge, language, QA, ...) (Poor 1 - 2 - 3 - 4 - 5 Excellent) 12345 Any extra comments on session 1? Session 2 Biosafety Accelerator PitchThe poster presentations were already rates during the poster prize. Meet the exhibitors - Quick introduction (Poor 1 - 2 - 3 - 4 - 5 Excellent) 12345 Any extra comments or remarks on session 2 ? Company presentationsPRI-BIO: Tissue Digester Options for Carcass Disposal from Animal Research Facilities Content (Poor 1 - 2 - 3 - 4 - 5 Excellent) 12345ERM: Safety Case: A new approach to Risk Management Content (Poor 1 - 2 - 3 - 4 - 5 Excellent) 12345Baker: BSC MYTHBUSTERS: CAN 2+ PEOPLE WORK IN A BSC SAFELY? Content (Poor 1 - 2 - 3 - 4 - 5 Excellent) 12345Actini: Thermal decontamination and sustainability : How can I become more sustainable ? Content (Poor 1 - 2 - 3 - 4 - 5 Excellent) 12345 Any extra comments or remarks on company presentations ? Chris Collins lectureA history of the world in 8 plaguesBy Jonathan Kennedy Content (Poor 1 - 2 - 3 - 4 - 5 Excellent) 12345 Speaker (knowledge, language, QA, ...) (Poor 1 - 2 - 3 - 4 - 5 Excellent) 12345 Any extra comments or remarks on the Chris Collins lecture? Session 3 - Implemeting BiosecurityBiosafety, Biosecurity and Dual-Use: Bridging the Gap Between Theory and Practical Implementation for Research InstitutesBy Timo Kehl Content (Poor 1 - 2 - 3 - 4 - 5 Excellent) 12345 Speaker (knowledge, language, QA, ...) (Poor 1 - 2 - 3 - 4 - 5 Excellent) 12345Implementing biosecurity in an academic environment: a headache?By Kathrin Summermatter Content (Poor 1 - 2 - 3 - 4 - 5 Excellent) 12345 Speaker (knowledge, language, QA, ...) (Poor 1 - 2 - 3 - 4 - 5 Excellent) Poor 1 - 2 - 3 - 4 - 5 Excellent 12345Bio- and cyber security solutions for biobanking and data management in high containment laboratoriesBy Julia Rieger Content (Poor 1 - 2 - 3 - 4 - 5 Excellent) 12345 Speaker (knowledge, language, QA, ...) (Poor 1 - 2 - 3 - 4 - 5 Excellent) 12345 Any extra comments or remarks on session 3 ? Session 4 New Technological Advances & Biosafety aspectsBiosafety & Biosecurity in support of Sustainable BiotechnologyBy Ursula Jenal Content (Poor 1 - 2 - 3 - 4 - 5 Excellent) 12345 Speaker (knowledge, language, QA, ...) (Poor 1 - 2 - 3 - 4 - 5 Excellent) 12345The convergence of biotechnology and Artificial Intelligence – Opportunities versus biosafety and biosecurity risksBy Rik Bleijs Content (Poor 1 - 2 - 3 - 4 - 5 Excellent) 12345 Speaker (knowledge, language, QA, ...) (Poor 1 - 2 - 3 - 4 - 5 Excellent) 12345Biocides destroying antibiotic resistance genes: an experimental investigationBy Suzanne Loret Content (Poor 1 - 2 - 3 - 4 - 5 Excellent) 12345 Speaker (knowledge, language, QA, ...) (Poor 1 - 2 - 3 - 4 - 5 Excellent) 12345 Any extra comments or remarks on session 4 ? Break outs Which break-outs did you attend? Break-out 1 Incident preparedness and incident management Break-out 2 insider threat Break-out 3 Solving problems without creating new – Biosafety challenges in the EU Nymphe bioremediation project Break-out 4 Biocide Product Regulation and biosafety: new insights and future perspectives Break-out 5 Bowtie Analysis: A Visual Risk Management Tool Break-out 1 Incident preparedness and incident management Content (Poor 1 - 2 - 3 - 4 - 5 Excellent) 12345 Any extra comments or remarks on Break-out 1 ? Break-out 2 insider threat Content (Poor 1 - 2 - 3 - 4 - 5 Excellent) 12345 Any extra comments or remarks on Break-out 2 ? Break-out 3 Solving problems without creating new – Biosafety challenges in the EU Nymphe bioremediation project Content (Poor 1 - 2 - 3 - 4 - 5 Excellent) 12345 Any extra comments or remarks on Break-out 3 ? Break-out 4 Biocide Product Regulation and biosafety: new insights and future perspectives Content (Poor 1 - 2 - 3 - 4 - 5 Excellent) 12345 Any extra comments or remarks on Break-out 4 ? Break-out 5 Bowtie Analysis: A Visual Risk Management Tool Content (Poor 1 - 2 - 3 - 4 - 5 Excellent) 12345 Any extra comments or remarks on Break-out 5 ? Session 5 Evidence-based Biosafety / Applied BiosafetyVirucidal activity of standard chemical disinfectants against Ebola virus suspended in tripartite soil and whole bloodBy Hulda R. Jonsdottir Content (Poor 1 - 2 - 3 - 4 - 5 Excellent) 12345 Speaker (knowledge, language, QA, ...) (Poor 1 - 2 - 3 - 4 - 5 Excellent) 12345The journey from “literature is always right” to a “trust but verify” culture when deciding upon a decontamination strategyBy Karen Gjendal Content (Poor 1 - 2 - 3 - 4 - 5 Excellent) 12345 Speaker (knowledge, language, QA, ...) (Poor 1 - 2 - 3 - 4 - 5 Excellent) Poor 1 - 2 - 3 - 4 - 5 Excellent 12345Widespread lentiviral plasmid contaminations in research laboratories pose a risk of accidental pseudotyping of lentiviral vectors – an analysis of LVV particles supernatants and plasmids sampled from swiss genetic laboratoriesBy Alina Teuscher Content (Poor 1 - 2 - 3 - 4 - 5 Excellent) 12345 Speaker (knowledge, language, QA, ...) (Poor 1 - 2 - 3 - 4 - 5 Excellent) 12345Extra Our ETWG colleagues would like to know if you have any topics you want to see addressed in a preconference course? Give your course ideas below Send
Conference Highlights & Feedback What was the most valuable or enjoyable aspect of the conference for you? (e.g., Specific session, speaker, networking opportunity, location, ...) Do you have any suggestions for improvement for the next conference? Thank you for the Quick feedback above. This is very usefull to the Conference Programming Working Group.If you want to help us even more we would be grateful if you filled out the full evaluation on content and speakers programmed in Antwerp last week.Just click the "Yes, I am up for it" option below. You want to fill out the full evaluation form? Yes, I am up for it No, thanks General organisation, location, conference office General evaluation (Poor 1 - 2 - 3 - 4 - 5 Excellent) 12345 Comments, remarks, questions, complaints, ... ? All feedback is welcome Session 1 - (Novel) Approaches in BioRisk AssessmentsEnhancing Biosafety Risk Assessments through technology and interactive tools: the role of WHO RAST in laboratory settingsBy Sandhya Dhawan Content (Poor 1 - 2 - 3 - 4 - 5 Excellent) 12345 Speaker (knowlegde, language, QA, ...) (Poor 1 - 2 - 3 - 4 - 5 Excellent) 12345Generic downscaling of containment requirements for work with viral replicons derived from alphaviruses and flavivirusesBy Clara Posthuma Content (Poor 1 - 2 - 3 - 4 - 5 Excellent) 12345 Speaker (knowledge, language, QA, ...) (Poor 1 - 2 - 3 - 4 - 5 Excellent) 12345Sleeper Agents in vertebrate DNA: Do Endogenous Retroviruses Pose Hidden Risks?By Yaël Vanden Abeele Content (Poor 1 - 2 - 3 - 4 - 5 Excellent) 12345 Speaker (knowledge, language, QA, ...) (Poor 1 - 2 - 3 - 4 - 5 Excellent) 12345 Any extra comments on session 1? Session 2 Biosafety Accelerator PitchThe poster presentations were already rates during the poster prize. Meet the exhibitors - Quick introduction (Poor 1 - 2 - 3 - 4 - 5 Excellent) 12345 Any extra comments or remarks on session 2 ? Company presentationsPRI-BIO: Tissue Digester Options for Carcass Disposal from Animal Research Facilities Content (Poor 1 - 2 - 3 - 4 - 5 Excellent) 12345ERM: Safety Case: A new approach to Risk Management Content (Poor 1 - 2 - 3 - 4 - 5 Excellent) 12345Baker: BSC MYTHBUSTERS: CAN 2+ PEOPLE WORK IN A BSC SAFELY? Content (Poor 1 - 2 - 3 - 4 - 5 Excellent) 12345Actini: Thermal decontamination and sustainability : How can I become more sustainable ? Content (Poor 1 - 2 - 3 - 4 - 5 Excellent) 12345 Any extra comments or remarks on company presentations ? Chris Collins lectureA history of the world in 8 plaguesBy Jonathan Kennedy Content (Poor 1 - 2 - 3 - 4 - 5 Excellent) 12345 Speaker (knowledge, language, QA, ...) (Poor 1 - 2 - 3 - 4 - 5 Excellent) 12345 Any extra comments or remarks on the Chris Collins lecture? Session 3 - Implemeting BiosecurityBiosafety, Biosecurity and Dual-Use: Bridging the Gap Between Theory and Practical Implementation for Research InstitutesBy Timo Kehl Content (Poor 1 - 2 - 3 - 4 - 5 Excellent) 12345 Speaker (knowledge, language, QA, ...) (Poor 1 - 2 - 3 - 4 - 5 Excellent) 12345Implementing biosecurity in an academic environment: a headache?By Kathrin Summermatter Content (Poor 1 - 2 - 3 - 4 - 5 Excellent) 12345 Speaker (knowledge, language, QA, ...) (Poor 1 - 2 - 3 - 4 - 5 Excellent) Poor 1 - 2 - 3 - 4 - 5 Excellent 12345Bio- and cyber security solutions for biobanking and data management in high containment laboratoriesBy Julia Rieger Content (Poor 1 - 2 - 3 - 4 - 5 Excellent) 12345 Speaker (knowledge, language, QA, ...) (Poor 1 - 2 - 3 - 4 - 5 Excellent) 12345 Any extra comments or remarks on session 3 ? Session 4 New Technological Advances & Biosafety aspectsBiosafety & Biosecurity in support of Sustainable BiotechnologyBy Ursula Jenal Content (Poor 1 - 2 - 3 - 4 - 5 Excellent) 12345 Speaker (knowledge, language, QA, ...) (Poor 1 - 2 - 3 - 4 - 5 Excellent) 12345The convergence of biotechnology and Artificial Intelligence – Opportunities versus biosafety and biosecurity risksBy Rik Bleijs Content (Poor 1 - 2 - 3 - 4 - 5 Excellent) 12345 Speaker (knowledge, language, QA, ...) (Poor 1 - 2 - 3 - 4 - 5 Excellent) 12345Biocides destroying antibiotic resistance genes: an experimental investigationBy Suzanne Loret Content (Poor 1 - 2 - 3 - 4 - 5 Excellent) 12345 Speaker (knowledge, language, QA, ...) (Poor 1 - 2 - 3 - 4 - 5 Excellent) 12345 Any extra comments or remarks on session 4 ? Break outs Which break-outs did you attend? Break-out 1 Incident preparedness and incident management Break-out 2 insider threat Break-out 3 Solving problems without creating new – Biosafety challenges in the EU Nymphe bioremediation project Break-out 4 Biocide Product Regulation and biosafety: new insights and future perspectives Break-out 5 Bowtie Analysis: A Visual Risk Management Tool Break-out 1 Incident preparedness and incident management Content (Poor 1 - 2 - 3 - 4 - 5 Excellent) 12345 Any extra comments or remarks on Break-out 1 ? Break-out 2 insider threat Content (Poor 1 - 2 - 3 - 4 - 5 Excellent) 12345 Any extra comments or remarks on Break-out 2 ? Break-out 3 Solving problems without creating new – Biosafety challenges in the EU Nymphe bioremediation project Content (Poor 1 - 2 - 3 - 4 - 5 Excellent) 12345 Any extra comments or remarks on Break-out 3 ? Break-out 4 Biocide Product Regulation and biosafety: new insights and future perspectives Content (Poor 1 - 2 - 3 - 4 - 5 Excellent) 12345 Any extra comments or remarks on Break-out 4 ? Break-out 5 Bowtie Analysis: A Visual Risk Management Tool Content (Poor 1 - 2 - 3 - 4 - 5 Excellent) 12345 Any extra comments or remarks on Break-out 5 ? Session 5 Evidence-based Biosafety / Applied BiosafetyVirucidal activity of standard chemical disinfectants against Ebola virus suspended in tripartite soil and whole bloodBy Hulda R. Jonsdottir Content (Poor 1 - 2 - 3 - 4 - 5 Excellent) 12345 Speaker (knowledge, language, QA, ...) (Poor 1 - 2 - 3 - 4 - 5 Excellent) 12345The journey from “literature is always right” to a “trust but verify” culture when deciding upon a decontamination strategyBy Karen Gjendal Content (Poor 1 - 2 - 3 - 4 - 5 Excellent) 12345 Speaker (knowledge, language, QA, ...) (Poor 1 - 2 - 3 - 4 - 5 Excellent) Poor 1 - 2 - 3 - 4 - 5 Excellent 12345Widespread lentiviral plasmid contaminations in research laboratories pose a risk of accidental pseudotyping of lentiviral vectors – an analysis of LVV particles supernatants and plasmids sampled from swiss genetic laboratoriesBy Alina Teuscher Content (Poor 1 - 2 - 3 - 4 - 5 Excellent) 12345 Speaker (knowledge, language, QA, ...) (Poor 1 - 2 - 3 - 4 - 5 Excellent) 12345Extra Our ETWG colleagues would like to know if you have any topics you want to see addressed in a preconference course? Give your course ideas below Send
